ADDvise signs global agreement with Laborie worth at least 38 MSEK.

ADDvise subsidiary Sonesta Medical AB, which develops and manufactures
medical devices for the urology/gynecology and incontinence market, has
signed a global distribution agreement with Toronto, Canada based
Laborie Medical Technologies, Inc.  The initial period for the agreement
is three years. Sales during this period is estimated to be worth at
least 38 million SEK.


This global distribution agreement is obviously a milestone for the
Sonesta business. Laborie has been for several years one of
Sonesta\'s distributors, primarily in the US, and the companies have now
agreed to further strengthen their relationships on a global basis, says
Rikard Akhtarzand CEO for the ADDvise Group in a comment to the
agreement. 

Laborie is the leading global developer, manufacturer and marketer of
innovative medical technology and consumables used for the diagnosis and
treatment of Urinary and Fecal Incontinence, as well as other pelvic
floor disorders in the Urology, Gynecology, and Colorectal fields. The
Sonesta products are an essential part of the complete solutions offered
by Laborie. Laborie is a global company and markets its products in over
80 countries.

Rikard Aktharzand, VD +46 765-25 90 71

rikard.akhtarzand@addvisegroup.se

 

About ADDvise Lab Solutions AB

ADDvise Lab Solutions AB (publ) is an expansive group which through its
subsidiaries IM-Medico Svenska AB, KEBO Inredningar Sverige AB, ADDvise
Tillquist AB, Sonesta Medical AB, Sonesta Medical Inc och Surgical
Tables Inc. offers comprehensive solutions in the form of products and
services to healthcare and research facilities. ADDvise Group\'s
customers are located in both the private and public sectors. The
Company\'s share is listed on First North and Mangold Fondkommission AB,
+46 8-503015 50, is the company\'s Certified Adviser and liquidity
provider.